Anthera Pharmaceuticals's current cash is $8.1M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Anthera Pharmaceuticals (ANTH) currently reports a current cash of $8.1M as of March 2018. That compares with $21M in the prior-year period — down 60.8% year over year. Use the charts on this page to explore Anthera Pharmaceuticals's current cash history and peer comparisons.
Anthera Pharmaceuticals's current cash decreased from $21M to $8.1M — a 60.8% year-over-year decrease (period ending March 2018). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Anthera Pharmaceuticals reported $8.1M in current cash as of March 2018. That compares with $21M in the prior-year period — down 60.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $8.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anthera Pharmaceuticals, and consider following ANTH for alerts when major investors trade the stock.
Anthera Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $8.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ANTH with unrelated industries.